IQ:NASDAQiQIYI, Inc. Analysis
Data as of 2026-09-11 - not real-time
$0.95
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $0.9524, iQIYI, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. The last 30 days have lost 25.6%. Momentum indicators put RSI at 40.7 (neutral) with MACD reading bullish. Recent trading has carved out support near $0.8600 and resistance around $1.37.
Multiples put this in undervalued territory: 11.5 times earnings against the sector's 15.5. The average analyst target implies 47.4% above today's level. Revenue is contracting at 5.1% on a -3.2% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 67.6%, a beta of 1.32 and a maximum drawdown of 68.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Multiples put this in undervalued territory: 11.5 times earnings against the sector's 15.5. The average analyst target implies 47.4% above today's level. Revenue is contracting at 5.1% on a -3.2% profit margin.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 67.6%, a beta of 1.32 and a maximum drawdown of 68.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Top Market Events
iQIYI NASDAQ:IQ shares dropped 3.0% in pre-market trading after the Chinese streaming company reported second-quarter...BEIJING, Aug. 18, 2026 GLOBE NEWSWIRE -- iQIYI, Inc. Nasdaq: IQ “iQIYI” or the “Company” , a leading provider...Yahoo Finance24diQIYI Inc IQ Q2 2026 Earnings Call Highlights: Strategic AI Shift Narrows Operating Loss by 80%Total...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 1.44
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 11.5 versus sector average of 15.5
- Trading below the 200-day average of 1.44
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 11.5 versus sector average of 15.5
- Negative profit margin of -3.2%
- Analyst targets imply +47.4% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth-5.10%
Profit Margin-3.22%
P/E Ratio11.5
ROE-6.73%
ROA-0.54%
Debt/Equity112.33
P/B Ratio0.5
Op. Cash Flow$305.6M
Free Cash Flow$12.7B
Industry P/E15.5
Technical Analysis
TrendBearish
RSI40.7
Support$0.86
Resistance$1.37
MA 20$1.01
MA 50$1.14
MA 200$1.44
MACDBullish
VolumeIncreasing
Fear & Greed Index93.14
Valuation
Fair Value$152.11
Target Price$1.40
Upside/Downside47.44%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.32
Volatility67.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.